Royal DSM Sells Half of Antibiotics Unit to Sinochem

Royal DSM NV sold 50% of its anti-infectives unit to Sinochem Group for $291 million, forming a JV between the two companies. Sinochem will use its extensive distribution network to market the JV’s antibiotics in China. DSM claims to be the global leader in beta-lactam antibiotics, the largest selling class in the world that includes penicillin derivatives such as cephalosporins. More details.... Stock Symbol: (XAMS: DSM)